https://doi.org/10.4081/monaldi.2024.2991
Hematological and clinical profiling of chronic obstructive pulmonary disease: a comprehensive study
Submitted: March 14, 2024
Accepted: August 9, 2024
Published: September 30, 2024
Accepted: August 9, 2024
Abstract Views: 535
PDF_EARLY VIEW: 140
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Chronic obstructive pulmonary disease (COPD) presents as a multifaceted clinical landscape with various hematological manifestations. Among these, polycythemia and anemia pose distinct challenges. While the prevalence of polycythemia has decreased in recent years, anemia remains a prevalent concern, impacting patient outcomes. This study investigated the incidence and clinical characteristics of polycythemia in COPD patients, focusing on a diverse cohort in India. Methodological approaches included comprehensive evaluations of clinical parameters, pulmonary function, and hematological profiles. Results revealed significant variations in COPD severity, pulmonary function, and respiratory symptoms among patients with different hemoglobin levels. The findings shed light on the complex interplay between hematological variations and clinical manifestations in COPD, providing valuable insights for disease management strategies.
Agustí A, Celli BR, Criner GJ, et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Am J Respirat Crit Care Med 2023;207:819-37.
DOI: https://doi.org/10.1164/rccm.202301-0106PP
Vlahakos V, Marathias K, Lionaki S, et al. The paradigm shift from polycythemia to anemia in COPD: the critical role of the renin–angiotensin system inhibitors. Expert Rev Respir Med 2022;16:391-8.
DOI: https://doi.org/10.1080/17476348.2022.2045958
Kollert F, Tippelt A, Müller C, et al. Hemoglobin levels above anemia thresholds are maximally predictive for long-term survival in COPD with chronic respiratory failure. Respir Care 2013;58:1204-12.
DOI: https://doi.org/10.4187/respcare.01961
Shujaat A, Minkin R, Eden E. Pulmonary hypertension and chronic cor pulmonale in COPD. Int J Chron Obstruct Pulmon Dis 2007;2:273-82.
Chambellan A, Chailleux E, Similowski T. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 2005;128:1201-8.
DOI: https://doi.org/10.1378/chest.128.3.1201
Alkhedaide AQ. Tobacco smoking causes secondary polycythemia and a mild leukocytosis among heavy smokers in Taif City in Saudi Arabia. Saudi J Biol Sci 2020;27:407-11.
DOI: https://doi.org/10.1016/j.sjbs.2019.11.001
McMullin M, Harrison C, Ali S, et al. A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline. Br J Haematol 2018;184:176-91.
DOI: https://doi.org/10.1111/bjh.15648
Rimal S, Das SK, Basnet A, et al. Prevalence and clinical impact of anemia in patients diagnosed with chronic obstructive pulmonary disease: a cross‐sectional study. Health Sci Rep 2023;6:e1371.
DOI: https://doi.org/10.1002/hsr2.1371
Balasubramanian A, Henderson RJ, Putcha N, et al. Haemoglobin as a biomarker for clinical outcomes in chronic obstructive pulmonary disease. ERJ Open Res 2021;7:00068-2021.
DOI: https://doi.org/10.1183/23120541.00068-2021
Ganesh M S, Satheesh S, Aravindhan S. Insights into the pathophysiology and therapeutic targets of consequences induced by polycythemia in COPD. Biotech Res Asia 2023;20.
DOI: https://doi.org/10.13005/bbra/3170
Zielinski J, Tobiasz M, Hawrylkiewicz I, et al. Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. Chest 1998;113:65-70.
DOI: https://doi.org/10.1378/chest.113.1.65
Zhang J, DeMeo DL, Silverman EK, et al. Secondary polycythemia in chronic obstructive pulmonary disease: prevalence and risk factors. BMC Pulm Med 2021;21:235.
DOI: https://doi.org/10.1186/s12890-021-01585-5
Masa JF, Pépin JL, Borel JC, et al. Obesity hypoventilation syndrome. Eur Respir Rev 2019;28:180097.
DOI: https://doi.org/10.1183/16000617.0097-2018
Semenza GL. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology 2009;24:97-106.
DOI: https://doi.org/10.1152/physiol.00045.2008
Pahal P, Hashmi MF, Sharma S. Chronic obstructive pulmonary disease compensatory measures. Treasure Island, FL, USA: StatPearls Publishing; 2024.
Sarkar M, Rajta PN, Khatana J. Anemia in chronic obstructive pulmonary disease: prevalence, pathogenesis, and potential impact. Lung India 2015;32:142-51.
DOI: https://doi.org/10.4103/0970-2113.152626
Kayrak M, Acar K, Gul EE, et al. Electrocardiographic findings in patients with polycythemia vera. Int J Med Sci 2012;9:93-102.
DOI: https://doi.org/10.7150/ijms.9.93
Ethics Approval
This study was approved by Institute Ethics Committee. All the patients were recruited in the study only after obtaining proper consent from the patients or their representatives (NITRD/PGEC/2019/5172).How to Cite
Sharma, Amit, Deepak Rathi, Prerna Jain, and Devika Tayal. 2024. “Hematological and Clinical Profiling of Chronic Obstructive Pulmonary Disease: A Comprehensive Study”. Monaldi Archives for Chest Disease, September. https://doi.org/10.4081/monaldi.2024.2991.
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Ravindra Nath, Neeraj Kumar Gupta, Amandeep Jaswal, Sparsh Gupta, Navjot Kaur, Santvana Kohli, Anirudh saxena, Pranav Ish, Rohit Kumar, Poornima Tiwari, Mukesh Kumar, Jugal Kishore, Geeta Yadav, Fellisha Marwein, Nitesh Gupta, Mortality among adult hospitalized patients during the first wave and second wave of COVID-19 pandemic at a tertiary care center in India , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Angelica Cersosimo, Gianmarco Arabia, Enrico Vizzardi, Marco Metra, Rapid progression of pulmonary artery dilatation in pulmonary hypertension , Monaldi Archives for Chest Disease: Vol. 93 No. 2 (2023)
- Rizk Sayad R. Sarhan, Omnia Y. Habashy, Raafat R. Mohammed, Yasmin M. Marei, Active versus latent pulmonary tuberculosis: which one is the appropriate distinguishing biomarker? , Monaldi Archives for Chest Disease: Early Access
- Shreyash Agrawal, Ravindra Nath, Pranav Ish, Neeraj Kumar Gupta, Rajni Gaind, Suniti Kale, Rani Gera, Anjali Dabral, Nitesh Gupta, *Other members of the Safdarjung Hospital COVID 2019 working group, Clinico-epidemiological profile of COVID-19 patients admitted during third wave of pandemic in a tertiary care hospital in New Delhi, India , Monaldi Archives for Chest Disease: Vol. 93 No. 2 (2023)
- Mahismita Patro, Nipun Malhotra, Dipti Gothi, Rahul Kumar, Ganjam Yasasvini, Diagnostic accuracy of daytime polysomnography: a reappraisal during the COVID-19 era , Monaldi Archives for Chest Disease: Early Access
- Astha Guliani, Abhishek Tandon, Amartya Chakroborty, Prem Parkash Gupta, Predictors of post COVID complications in patients admitted with moderate to severe COVID symptoms: A single center, prospective, observational study , Monaldi Archives for Chest Disease: Vol. 93 No. 2 (2023)
- Unnati Desai, Saby AK, Ketaki Utpat, Jyoti Bacche, Role of GeneXpert in the diagnosis of extrapulmonary tuberculosis , Monaldi Archives for Chest Disease: Early Access
- Vasiliki Epameinondas Georgakopoulou, Nikolaos Garmpis, Dimitrios Mermigkis, Christos Damaskos, Serafeim Chlapoutakis, Konstantinos Mantzouranis, Aikaterini Gkoufa, Chrysovalantis Papageorgiou, Anna Garmpi, Sotiria Makrodimitri, Evangelos Diamantis, Pagona Sklapani, Nikolaos Trakas, Xanthi Tsiafaki, Pulmonary adverse events due to immune checkpoint inhibitors: A literature review , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Venkata Nagarjuna Maturu, Anand Vijay, Virender Pratibh Prasad, Rinoosha Rechal, Vipul Kumar Garg, Shweta Sethi, Comparison of diagnostic yield and safety of endobronchial ultrasound-guided mediastinal lymph nodal cryobiopsy and endobronchial ultrasound-guided Franseen tip needle biopsy , Monaldi Archives for Chest Disease: Early Access
- Aninda Debnath, Ravindra Nath, Anubhav Mondal, Pankaj Chandrabhan Nathe, Jugal Kishore, Pranav Ish, Vidushi Rathi, Jagdish Kaur, Prevalence of tobacco consumption among pulmonary tuberculosis patients and its correlation with tuberculosis incidence: a systematic review and meta-analysis in the Indian context , Monaldi Archives for Chest Disease: Early Access
<< < 31 32 33 34 35 36 37 38 39 40 > >>
You may also start an advanced similarity search for this article.
